Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2019-08-09 6:40 pm Sale | 13D | Alector Inc. ALEC | ORBIMED ADVISORS LLC | 12,240,829 17.77% | -650,000 (-5.04%) | View |
| 2019-07-02 4:22 pm Purchase | 13D | Corvus Pharmaceuticals Inc. CRVS | ORBIMED ADVISORS LLC | 6,624,928 22.6% | 657,344 (+11.02%) | View |
| 2019-06-27 1:20 pm Purchase | 13D | Prevail Therapeutics Inc. PRVL | ORBIMED ADVISORS LLC | 13,822,463 40.7% | 13,822,463 (New Position) | View |